InsiderTrades

Form 4 for ELV Elevance Health

Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001156039-23-000030 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-03-03 2023-03-01 ELV Todt Blair Williams EVP, CLO F - Tax $469.03 -372 7,911 -4% -$174.5K
DM 2023-03-03 2023-03-01 ELV Todt Blair Williams EVP, CLO A - Grant $0.00 +4,717 12.6K +60% $0
D 2023-03-03 2023-03-01 ELV Todt Blair Williams EVP, CLO A - Grant $0.00 +8,195 8,195 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-01 F D 372 $469.03 7,911 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
2 Common Common Stock 2023-03-01 A A 2,133 $0.00 10,044 D — — (F2) Represents restricted share units. Restrictions lapse as follows: 711 shares each on 3/1/2024, 3/1/2025 and 3/1/2026.
3 Common Common Stock 2023-03-01 A A 2,584 $0.00 12,628 D — — (F3) Represents performance based restricted share units. Restrictions lapse on 12/1/2023.
4 Derivative Employee Stock Option (Right to Buy) 2023-03-01 A A 8,195 $0.00 8,195 D $469.03 · — to 2033-03-01 8,195 Common Stock (F4) The option represents a right to purchase a total of 8,195 shares, and is exercisable in one installment of 2,731 and two installments of 2,732 each, beginning on 3/1/2024 which is the one-year anniversary of the option grant date.